
Looking to sell Viz.ai stock or options?
Viz.ai develops an intelligent care coordination platform aimed at transforming global healthcare delivery. The platform utilizes advanced deep learning to promptly relay critical information about stroke patients directly to specialists for timely intervention. This technology enables healthcare providers to expedite treatment times and enhance access to care.





HighGear Ventures, Camford Capital, Susa Ventures, AME Cloud Ventures, Seedcamp, Kevin Ding, Threshold Ventures, Jukka Jokinen, ARC Innovation Center, Halle Tecco.
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Read moreViz.ai Integrates Avicenna.AI's Tools for ASPECTS Stroke Severity Assessment and Incidental Pulmonary Embolism into Viz.ai One Platform
Read moreSAN FRANCISCO - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced Chris Mansi, MD, CEO and Co-founder, will present at the Morgan Stanley 22nd...
Read moreCollaboration aims to help cryptogenic stroke patients receive necessary cardiology follow-up to reduce risk of secondary strokeSAN FRANCISCO--(BUSINESS
Read moreNew AI algorithm enables precise and reliable quantification of intracerebral hemorrhage to make accurate and timely treatment decisionsSAN
Read moreThe AI-powered diagnostic platform can diagnose the presence of aneurysms by analysing computed tomography (CT) scans.
Read more